AAAAAA

   
Results: 1-18 |
Results: 18
SHIGELLA GASTROENTERITIS - CLINICAL AND EPIDEMIOLOGIC ASPECTS, AND ANTIBIOTIC SUSCEPTIBILITY
Authors: YURDAKOK K SAHIN N OZMERT E BERKMAN E
Citation: K. Yurdakok et al., SHIGELLA GASTROENTERITIS - CLINICAL AND EPIDEMIOLOGIC ASPECTS, AND ANTIBIOTIC SUSCEPTIBILITY, Acta Paediatrica Japonica Overseas Edition, 39(6), 1997, pp. 681-684
ANTIBIOTIC SUSCEPTIBILITIES OF SALMONELLA SEROGROUPS ISOLATED FROM TURKISH CHILDREN
Authors: AKAN O KANRA G SECMEER G CEYHAN M ECEVIT Z BERKMAN E
Citation: O. Akan et al., ANTIBIOTIC SUSCEPTIBILITIES OF SALMONELLA SEROGROUPS ISOLATED FROM TURKISH CHILDREN, Turkish Journal of Pediatrics, 39(1), 1997, pp. 7-11
ANTIBIOTIC SUSCEPTIBILITIES OF ENTEROCOCCI ISOLATED FROM TURKISH CHILDREN
Authors: AKAN O KANRA G ECEVIT Z CEYHAN M SECMEER G BERKMAN E
Citation: O. Akan et al., ANTIBIOTIC SUSCEPTIBILITIES OF ENTEROCOCCI ISOLATED FROM TURKISH CHILDREN, Turkish Journal of Pediatrics, 39(1), 1997, pp. 13-17
COMPARISON OF STANDARD AND SHORT-COURSE METHOTREXATE (MTX) IN COMBINATION WITH ADJUSTED-DOSE CONTINUOUS-INFUSION CYCLOSPORINE-A (CSA) TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD)
Authors: KOC Y MILLER KB SCHENKEIN DP SPRAGUE K BERKMAN E
Citation: Y. Koc et al., COMPARISON OF STANDARD AND SHORT-COURSE METHOTREXATE (MTX) IN COMBINATION WITH ADJUSTED-DOSE CONTINUOUS-INFUSION CYCLOSPORINE-A (CSA) TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD), Blood, 90(10), 1997, pp. 4413-4413
THE ROLE OF SPLENIC IRRADIATION (XRT) PRIOR TO BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOID-LEUKEMIA (CML)
Authors: JABRO G KOC Y MILLER K BOYLE T RAVALESE J SCHENKEIN D SPRAGUE K BERKMAN E
Citation: G. Jabro et al., THE ROLE OF SPLENIC IRRADIATION (XRT) PRIOR TO BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOID-LEUKEMIA (CML), Blood, 90(10), 1997, pp. 1669-1669
VARICELLA-ZOSTER VIRUS-INFECTIONS (VZV) FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) - FREQUENCY, RISK-FACTORS, CLINICAL OUTCOME AND ANTIVIRAL PROPHYLAXIS
Authors: KOC Y MILLER K SCHENKEIN D SPRAGUE K BERKMAN E DESJARDIN J SYNDMAN D
Citation: Y. Koc et al., VARICELLA-ZOSTER VIRUS-INFECTIONS (VZV) FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) - FREQUENCY, RISK-FACTORS, CLINICAL OUTCOME AND ANTIVIRAL PROPHYLAXIS, Blood, 90(10), 1997, pp. 2420-2420
CHANGING PATTERNS OF THE PREVALENCE OF DIFFERENT SHIGELLA SPECIES ANDTHEIR ANTIBIOTIC SUSCEPTIBILITIES IN ANKARA, TURKEY
Authors: CEYHAN M AKAN O KANRA C ECEVIT Z SECMEER G BERKMAN E
Citation: M. Ceyhan et al., CHANGING PATTERNS OF THE PREVALENCE OF DIFFERENT SHIGELLA SPECIES ANDTHEIR ANTIBIOTIC SUSCEPTIBILITIES IN ANKARA, TURKEY, Journal of diarrhoeal diseases research, 14(3), 1996, pp. 187-189
THE TREATMENT OF REFRACTORY OR SECONDARY LEUKEMIA WITH INDUCTION THERAPY AND AN ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO-BMT)
Authors: SPRAGUE KA MILLER KB SCHENKEIN DP HURLEY CA BERKMAN E
Citation: Ka. Sprague et al., THE TREATMENT OF REFRACTORY OR SECONDARY LEUKEMIA WITH INDUCTION THERAPY AND AN ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO-BMT), Blood, 88(10), 1996, pp. 2445-2445
USE OF CYTOMEGALOVIRUS IMMUNOGLOBULIN IN MULTIPLY TRANSFUSED PREMATURE NEONATES
Authors: SNYDMAN DR WERNER BG MEISSNER HC CHEESEMAN SH SCHWAB J BEDNAREK F KENNEDY JL HERSCHEL M MAGNO A LEVIN MJ VALAES T BERKMAN E MCIVER J LESZCZYNSKI J GRIFFITH J GRADY GF
Citation: Dr. Snydman et al., USE OF CYTOMEGALOVIRUS IMMUNOGLOBULIN IN MULTIPLY TRANSFUSED PREMATURE NEONATES, The Pediatric infectious disease journal, 14(1), 1995, pp. 34-40
PROLONGED COURSE OF ADJUSTED-DOSE INTRAVENOUS CYCLOSPORINE AND SHORT-COURSE OF METHOTREXATE TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD)
Authors: MILLER K SCHENKEIN D ERBAN J HURLEY C BERKMAN E
Citation: K. Miller et al., PROLONGED COURSE OF ADJUSTED-DOSE INTRAVENOUS CYCLOSPORINE AND SHORT-COURSE OF METHOTREXATE TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD), Blood, 86(10), 1995, pp. 1572-1572
PHASE-I TRIAL OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY WITH GCSF PRIMED PERIPHERAL-BLOOD STEM-CELL RESCUE IN PATIENTS WITH ADVANCED CANCER
Authors: WECKSTEIN D SPRAGUE K HURLEY C KARP D BERKMAN E CURTIN P SCHENKEIN D SWEET M MILLER K
Citation: D. Weckstein et al., PHASE-I TRIAL OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY WITH GCSF PRIMED PERIPHERAL-BLOOD STEM-CELL RESCUE IN PATIENTS WITH ADVANCED CANCER, Blood, 86(10), 1995, pp. 3881-3881
ADJUSTED-DOSE CONTINUOUS-INFUSION CYCLOSPORINE-A TO PREVENT GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: MILLER KB SCHENKEIN DP ERBAN JK COMENZO R FOGAREN T BERKMAN E RABSON A HIRSCH CA
Citation: Kb. Miller et al., ADJUSTED-DOSE CONTINUOUS-INFUSION CYCLOSPORINE-A TO PREVENT GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Annals of hematology, 68(1), 1994, pp. 15-20
PHASE I II STUDY OF CYCLOPHOSPHAMIDE, CARBOPLATIN, AND ETOPOSIDE AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION WITH POSTTRANSPLANTINTERFERON ALFA-2B FOR PATIENTS WITH LYMPHOMA AND HODGKINS-DISEASE/
Authors: SCHENKEIN DP DIXON P DESFORGES JF BERKMAN E ERBAN JK ASCENSAO JL MILLER KB
Citation: Dp. Schenkein et al., PHASE I II STUDY OF CYCLOPHOSPHAMIDE, CARBOPLATIN, AND ETOPOSIDE AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION WITH POSTTRANSPLANTINTERFERON ALFA-2B FOR PATIENTS WITH LYMPHOMA AND HODGKINS-DISEASE/, Journal of clinical oncology, 12(11), 1994, pp. 2423-2431
A RANDOMIZED TRIAL OF FILGRASTIM (G-CSF) PRIMED PERIPHERAL-BLOOD STEM-CELLS (PBSC) VS BONE-MARROW AS A RECONSTITUTION SOURCE FOR HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH LYMPHOMA AND HODGKINS-DISEASE - AN INTERIM CLINICAL AND MOLECULAR ANALYSIS
Authors: SCHENKEIN DP MCCANN L KANTETI R BERKMAN E ERBAN J WECKSTEIN D SWEET M MILLER K
Citation: Dp. Schenkein et al., A RANDOMIZED TRIAL OF FILGRASTIM (G-CSF) PRIMED PERIPHERAL-BLOOD STEM-CELLS (PBSC) VS BONE-MARROW AS A RECONSTITUTION SOURCE FOR HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH LYMPHOMA AND HODGKINS-DISEASE - AN INTERIM CLINICAL AND MOLECULAR ANALYSIS, Blood, 84(10), 1994, pp. 10000204-10000204
AN IGM-KAPPA PARAPROTEIN IN A PATIENT WITH WALDENSTROM MACROGLOBULIN HAS ANTI-PR COLD ANTIBODY SPECIFICITY AND IS ALSO A CRYOGLOBULIN AND HAS PROGENITOR-CELL SUPPRESSIVE PROPERTIES
Authors: NOVARETTI M KHURI F MILLER K BERKMAN E
Citation: M. Novaretti et al., AN IGM-KAPPA PARAPROTEIN IN A PATIENT WITH WALDENSTROM MACROGLOBULIN HAS ANTI-PR COLD ANTIBODY SPECIFICITY AND IS ALSO A CRYOGLOBULIN AND HAS PROGENITOR-CELL SUPPRESSIVE PROPERTIES, Transfusion, 33(9), 1993, pp. 190000025-190000025
MONONUCLEAR, CD-34-CELL RECOVERY IN UNSEPARATED AND SEPARATED UMBILICAL-CORD BLOOD BEFORE AND AFTER CRYOPRESERVATION(, AND PROGENITOR)
Authors: MALACHOWSKI M CETRULO C BERKMAN E
Citation: M. Malachowski et al., MONONUCLEAR, CD-34-CELL RECOVERY IN UNSEPARATED AND SEPARATED UMBILICAL-CORD BLOOD BEFORE AND AFTER CRYOPRESERVATION(, AND PROGENITOR), Transfusion, 33(9), 1993, pp. 190000047-190000047
MONONUCLEAR AND PROGENITOR-CELL RECOVERY FROM UMBILICAL-CORD BLOOD BYDENSITY GRADIENT CENTRIFUGATION
Authors: MALACHOWSKI M CETRULO C CETRULO C BERKMAN E
Citation: M. Malachowski et al., MONONUCLEAR AND PROGENITOR-CELL RECOVERY FROM UMBILICAL-CORD BLOOD BYDENSITY GRADIENT CENTRIFUGATION, Transfusion, 33(9), 1993, pp. 190000073-190000073
ADJUSTED-DOSE CONTINUOUS-INFUSION CYCLOSPORINE-A TO PREVENT GRAFT-VERSUS-HOST DISEASE
Authors: MILLER K SCHENKEIN D COMENZO R ERBAN J FOGAREN T HIRSCH C BERKMAN E RABSON A
Citation: K. Miller et al., ADJUSTED-DOSE CONTINUOUS-INFUSION CYCLOSPORINE-A TO PREVENT GRAFT-VERSUS-HOST DISEASE, Blood, 82(10), 1993, pp. 10000419-10000419
Risultati: 1-18 |